In addition, the immunoregulatory effect of CXCL9, CXCL10, and the CXCL11/CXCR3 axis on tumor sites to promote antitumor immunity has been used as a new tumor therapeutic target (Tokunaga et al., 2018). Here, CXCL9 is linked to neoplasm.